Editas Medicine (EDIT)

$5.61 0.24 (4.10%)
16:00 EDT EDIT Stock Quote Delayed 30 Minutes

3 Biotech Stocks That Are Set for a Breakthrough

By InvestorPlace Research Staff
If you're looking for biotech stocks to buy with massive breakthrough potential in gene editing, then these three are kings among the rest.

Gene Editing is a Major Technology to Watch

Whole Foods Market, Inc. (WFM) and Xtant Medical Holdings Inc (XTNT) Lead 13 Activist Investment Filings

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 457.96M
PE Ratio -2.76
EPS -2.03
Volume (Avg. Vol.) 1.91M
Day's Range $5.60 - $5.93
52-Week Range $5.60 - $11.91
Dividend & Yield N/A (N/A)